Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Sixty-six percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20% in placebo group.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there is no substantial evidence that they directly increase the risk for vascular events.
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
The AANA has rebranded as the American Association of Nurse Anesthesiology as part of a yearlong effort designed to advance the science of nurse anesthesiology and advocate for CRNAs.
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
The majority of APRNs report low levels of preparedness in caring for patients with basic chronic or acute pain management needs in their first year of practice.
The CDC offers 4 resources to support Nurse Practitioners in implementing opioid guidelines.
Global assessments at six and 24 hours better with NSAID use, and fewer adverse effects, including bleeding events, reported
